Skip to main content
Caplight Logo









LabSpinner

LabSpinner

Private
UlsanHealthcare & Life Scienceshttps://labspinner.com/

Last Round

Series A

Aug 24, 2024

Total Funding Raised

$3.82M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

LabSpinner is a biotechnology company that develops microfluidic devices for automated laboratory procedures, specifically focusing on exosome and extracellular vesicle isolation.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Medical Devices, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

extracellular vesicle isolationEV isolationexosome isolationmicrofluidic deviceslab-on-a-chipliquid biopsybiomarker discoveryautomated sample preparationcentrifugal microfluidicsbenchtop laboratory instrumentregenerative medicinedisposable cartridgesEV analysisbiotech instrumentation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

LabSpinner Comparables

Compare LabSpinner with similar companies based on industry and business-model similarity.

LabSpinner comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Exodus Bio
86%
WellSIM BioMedical Technologies Inc.
83%
Everest Biolabs
83%

LabSpinner Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AAug 24, 2024
GrantJun 18, 2024
AcceleratorJan 11, 2024

Key People

Founding team and executive leadership

이범석 David BS Lee

CTO

Executive Team

LabSpinner Investors

Notable investors and investment history

LabSpinner investors
InvestorRounds
KOTECSeries A
ActnerLabSeries A
IBK ChanggongAccelerator
UNIST HoldingsSeries A
Government of South KoreaGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 138% MoM, reaching 2K.

  • May 19, 2026

    Monthly visitors increased 63% MoM.

LabSpinner Filings

Explore SEC and related filing metadata, where available.

LabSpinner filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about LabSpinner's valuation, stock price, and market status.

Is LabSpinner a public or private company?

LabSpinner is a private company.

What is the current stock price of LabSpinner?

LabSpinner is a private company with no public stock price. No recent secondary market data is available.

How much is LabSpinner worth (valuation)?

Valuation information for LabSpinner is not publicly available.

Can I buy LabSpinner stock?

LabSpinner shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was LabSpinner's last funding round?

LabSpinner's most recent funding round was Series A on August 24, 2024.

Who are the main investors in LabSpinner?

Key investors in LabSpinner include KOTEC, ActnerLab, IBK Changgong, UNIST Holdings, Government of South Korea.

Will LabSpinner IPO soon?

No public IPO plans have been announced for LabSpinner.

How can I track LabSpinner secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor LabSpinner's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersUlsan
Employee Range11
Year Founded2018
Last FundingAug 24, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?